Topics / tentative sessions
(as of 06 May 2019)
► |
Refinement: best practice approaches, animal welfare, avoidance of severe suffering, culture of care |
► |
Reduction: transparency, reproducibility and translational aspects (species differences) |
► |
Replacement - advanced technologies: bio-printing, -omics technologies, systems biology approaches, IT and big data
|
► |
Banning the 90-day dog study for the safety testing of human drugs and pharmaceuticals |
► |
3Rs in education and academia |
► |
3R Centers in Europe & international - national and local centers |
► |
International progress in 3Rs research: New Funding Initiatives & Global Cooperation
|
► |
3D Models & multi-organ-chips (MOC), human-organ-chips (HOC) |
► |
Biological barriers: e.g. lung, gut, kidney & skin epithelia, blood-brain & blood-saliva barriers
|
► |
In Silico Models: toxicology & efficacy of drugs, chemicals & cosmetics, new approaches for biomedical research |
► |
Disease models using HUMAN cells, tissues and organs
|
► |
Efficacy and safety testing of drugs, medical devices & biopharmaceutics (incl. vaccines, blood components, allergenics, somatic cells, gene therapies, tissues and living cells used in therapy)
|
► |
REACH - the most frequently used alternatives: Read Across, WoE (Weight of Evidence), QSAR
|
► |
Advanced safety testing of cosmetics and consumer products (e. g. toys)
|
► |
Alternatives to animal testing in food safety, nutrition and efficacy |
► |
Specific Endpoints of Toxicity: repeated-dose toxicity, inhalation, sensitization, reproductive & developmental toxicity (mEST & hEST), carcinogenesis, nanotoxicology
|
► |
Neurotoxicity & Developmental Neurotoxicity (DNT) |
► |
Ecotoxicology |
► |
Stem cell models and technology (hIPS, ES, mES, mIPS…)
|
► |
Implementing EU Dir 63/2010 - update
|
► |
Ethical & legal issues |
► |
Advanced GMO models – CRISPR/Cas in vivo & in vitro |
► |
Initiative for Implementing Serum Free Culture Media |
► |
Publication policies regarding animal experiments and the 3Rs principles |
► |
An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment: Results of the in3 project |
► |
Vaccines: safety testing & the 3Rs |
► |
Botulium neurotoxin (BoNT) - serotyping of c. botulinum and potency testing of BoTN products |
► |
"Young Scientists" session |
► |
Free communications |
 |
|
► |
You miss a topic? You want your topic to be discussed? You are interested in organizing a session dealing with your topic? Get in contact with us! congress2019@eusaat-congress.eu
|
| |
|
Deadlines for your submission of abstracts:- Submission of oral presentations: closed extended until 15 July 2019 Missed the deadline? Contact the congress office! To submit your abstract for oral presentations or poster please use our online submission system! Please stay in touch: congress2019@eusaat-congress.eu or subscribe to the newsletter! If you've any questions, please contact the congress office! |
|
|
paid advertising
|
paid advertising
|
